1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Analysis & Transcriptomic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2M4266
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global RNA Analysis Transcriptomic Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global RNA Analysis & Transcriptomic Market Research Report 2025

Code: QYRE-Auto-2M4266
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

RNA Analysis & Transcriptomic Market

The global market for RNA Analysis & Transcriptomic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for RNA Analysis & Transcriptomic in Clinical Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of RNA Analysis & Transcriptomic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis & Transcriptomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.
The RNA Analysis & Transcriptomic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Analysis & Transcriptomic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis & Transcriptomic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of RNA Analysis & Transcriptomic Market Report

Report Metric Details
Report Name RNA Analysis & Transcriptomic Market
Segment by Type
  • Microarrays
  • Sequencing
  • Polymerase Chain Reaction
  • RNA Interference
Segment by Application
  • Clinical Diagnostics
  • Drug Discovery
  • Toxicogenomics
  • Comparative Transcriptomics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioMérieux SA, LC Sciences LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of RNA Analysis & Transcriptomic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Analysis & Transcriptomic Market report?

Ans: The main players in the RNA Analysis & Transcriptomic Market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioMérieux SA, LC Sciences LLC

What are the Application segmentation covered in the RNA Analysis & Transcriptomic Market report?

Ans: The Applications covered in the RNA Analysis & Transcriptomic Market report are Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics

What are the Type segmentation covered in the RNA Analysis & Transcriptomic Market report?

Ans: The Types covered in the RNA Analysis & Transcriptomic Market report are Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis & Transcriptomic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Toxicogenomics
1.3.5 Comparative Transcriptomics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis & Transcriptomic Market Perspective (2020-2031)
2.2 Global RNA Analysis & Transcriptomic Growth Trends by Region
2.2.1 Global RNA Analysis & Transcriptomic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNA Analysis & Transcriptomic Historic Market Size by Region (2020-2025)
2.2.3 RNA Analysis & Transcriptomic Forecasted Market Size by Region (2026-2031)
2.3 RNA Analysis & Transcriptomic Market Dynamics
2.3.1 RNA Analysis & Transcriptomic Industry Trends
2.3.2 RNA Analysis & Transcriptomic Market Drivers
2.3.3 RNA Analysis & Transcriptomic Market Challenges
2.3.4 RNA Analysis & Transcriptomic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis & Transcriptomic Players by Revenue
3.1.1 Global Top RNA Analysis & Transcriptomic Players by Revenue (2020-2025)
3.1.2 Global RNA Analysis & Transcriptomic Revenue Market Share by Players (2020-2025)
3.2 Global RNA Analysis & Transcriptomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Analysis & Transcriptomic Revenue
3.4 Global RNA Analysis & Transcriptomic Market Concentration Ratio
3.4.1 Global RNA Analysis & Transcriptomic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis & Transcriptomic Revenue in 2024
3.5 Global Key Players of RNA Analysis & Transcriptomic Head office and Area Served
3.6 Global Key Players of RNA Analysis & Transcriptomic, Product and Application
3.7 Global Key Players of RNA Analysis & Transcriptomic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis & Transcriptomic Breakdown Data by Type
4.1 Global RNA Analysis & Transcriptomic Historic Market Size by Type (2020-2025)
4.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2026-2031)
5 RNA Analysis & Transcriptomic Breakdown Data by Application
5.1 Global RNA Analysis & Transcriptomic Historic Market Size by Application (2020-2025)
5.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNA Analysis & Transcriptomic Market Size (2020-2031)
6.2 North America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNA Analysis & Transcriptomic Market Size by Country (2020-2025)
6.4 North America RNA Analysis & Transcriptomic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis & Transcriptomic Market Size (2020-2031)
7.2 Europe RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNA Analysis & Transcriptomic Market Size by Country (2020-2025)
7.4 Europe RNA Analysis & Transcriptomic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis & Transcriptomic Market Size (2020-2031)
8.2 Asia-Pacific RNA Analysis & Transcriptomic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2020-2025)
8.4 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis & Transcriptomic Market Size (2020-2031)
9.2 Latin America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNA Analysis & Transcriptomic Market Size by Country (2020-2025)
9.4 Latin America RNA Analysis & Transcriptomic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis & Transcriptomic Market Size (2020-2031)
10.2 Middle East & Africa RNA Analysis & Transcriptomic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2020-2025)
10.4 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Details
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis & Transcriptomic Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Details
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Introduction
11.4.4 Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation RNA Analysis & Transcriptomic Introduction
11.6.4 Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.6.5 Danaher Corporation Recent Development
11.7 Fluidigm Corporation
11.7.1 Fluidigm Corporation Company Details
11.7.2 Fluidigm Corporation Business Overview
11.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Introduction
11.7.4 Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.7.5 Fluidigm Corporation Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Introduction
11.8.4 Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.8.5 Eurofins Scientific Recent Development
11.9 Sequentia Biotech SL
11.9.1 Sequentia Biotech SL Company Details
11.9.2 Sequentia Biotech SL Business Overview
11.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Introduction
11.9.4 Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.9.5 Sequentia Biotech SL Recent Development
11.10 Acobiom
11.10.1 Acobiom Company Details
11.10.2 Acobiom Business Overview
11.10.3 Acobiom RNA Analysis & Transcriptomic Introduction
11.10.4 Acobiom Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.10.5 Acobiom Recent Development
11.11 GenXPro GmbH
11.11.1 GenXPro GmbH Company Details
11.11.2 GenXPro GmbH Business Overview
11.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Introduction
11.11.4 GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.11.5 GenXPro GmbH Recent Development
11.12 CD Genomics
11.12.1 CD Genomics Company Details
11.12.2 CD Genomics Business Overview
11.12.3 CD Genomics RNA Analysis & Transcriptomic Introduction
11.12.4 CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.12.5 CD Genomics Recent Development
11.13 Promega Corporation
11.13.1 Promega Corporation Company Details
11.13.2 Promega Corporation Business Overview
11.13.3 Promega Corporation RNA Analysis & Transcriptomic Introduction
11.13.4 Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.13.5 Promega Corporation Recent Development
11.14 Cenix BioScience GmbH
11.14.1 Cenix BioScience GmbH Company Details
11.14.2 Cenix BioScience GmbH Business Overview
11.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Introduction
11.14.4 Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.14.5 Cenix BioScience GmbH Recent Development
11.15 Takara Holdings, Inc.
11.15.1 Takara Holdings, Inc. Company Details
11.15.2 Takara Holdings, Inc. Business Overview
11.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Introduction
11.15.4 Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.15.5 Takara Holdings, Inc. Recent Development
11.16 bioMérieux SA
11.16.1 bioMérieux SA Company Details
11.16.2 bioMérieux SA Business Overview
11.16.3 bioMérieux SA RNA Analysis & Transcriptomic Introduction
11.16.4 bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.16.5 bioMérieux SA Recent Development
11.17 LC Sciences LLC
11.17.1 LC Sciences LLC Company Details
11.17.2 LC Sciences LLC Business Overview
11.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Introduction
11.17.4 LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2020-2025)
11.17.5 LC Sciences LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Microarrays
 Table 3. Key Players of Sequencing
 Table 4. Key Players of Polymerase Chain Reaction
 Table 5. Key Players of RNA Interference
 Table 6. Global RNA Analysis & Transcriptomic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global RNA Analysis & Transcriptomic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global RNA Analysis & Transcriptomic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global RNA Analysis & Transcriptomic Market Share by Region (2020-2025)
 Table 10. Global RNA Analysis & Transcriptomic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global RNA Analysis & Transcriptomic Market Share by Region (2026-2031)
 Table 12. RNA Analysis & Transcriptomic Market Trends
 Table 13. RNA Analysis & Transcriptomic Market Drivers
 Table 14. RNA Analysis & Transcriptomic Market Challenges
 Table 15. RNA Analysis & Transcriptomic Market Restraints
 Table 16. Global RNA Analysis & Transcriptomic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global RNA Analysis & Transcriptomic Market Share by Players (2020-2025)
 Table 18. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2024)
 Table 19. Ranking of Global Top RNA Analysis & Transcriptomic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by RNA Analysis & Transcriptomic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of RNA Analysis & Transcriptomic, Headquarters and Area Served
 Table 22. Global Key Players of RNA Analysis & Transcriptomic, Product and Application
 Table 23. Global Key Players of RNA Analysis & Transcriptomic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global RNA Analysis & Transcriptomic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2020-2025)
 Table 27. Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2026-2031)
 Table 29. Global RNA Analysis & Transcriptomic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2020-2025)
 Table 31. Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2026-2031)
 Table 33. North America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific RNA Analysis & Transcriptomic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Thermo Fisher Scientific, Inc. Company Details
 Table 49. Thermo Fisher Scientific, Inc. Business Overview
 Table 50. Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Product
 Table 51. Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 52. Thermo Fisher Scientific, Inc. Recent Development
 Table 53. Bio-Rad Laboratories, Inc. Company Details
 Table 54. Bio-Rad Laboratories, Inc. Business Overview
 Table 55. Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Product
 Table 56. Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 57. Bio-Rad Laboratories, Inc. Recent Development
 Table 58. Merck KGaA Company Details
 Table 59. Merck KGaA Business Overview
 Table 60. Merck KGaA RNA Analysis & Transcriptomic Product
 Table 61. Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 62. Merck KGaA Recent Development
 Table 63. Agilent Technologies, Inc. Company Details
 Table 64. Agilent Technologies, Inc. Business Overview
 Table 65. Agilent Technologies, Inc. RNA Analysis & Transcriptomic Product
 Table 66. Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 67. Agilent Technologies, Inc. Recent Development
 Table 68. F. Hoffmann-La Roche Ltd. Company Details
 Table 69. F. Hoffmann-La Roche Ltd. Business Overview
 Table 70. F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Product
 Table 71. F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 72. F. Hoffmann-La Roche Ltd. Recent Development
 Table 73. Danaher Corporation Company Details
 Table 74. Danaher Corporation Business Overview
 Table 75. Danaher Corporation RNA Analysis & Transcriptomic Product
 Table 76. Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 77. Danaher Corporation Recent Development
 Table 78. Fluidigm Corporation Company Details
 Table 79. Fluidigm Corporation Business Overview
 Table 80. Fluidigm Corporation RNA Analysis & Transcriptomic Product
 Table 81. Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 82. Fluidigm Corporation Recent Development
 Table 83. Eurofins Scientific Company Details
 Table 84. Eurofins Scientific Business Overview
 Table 85. Eurofins Scientific RNA Analysis & Transcriptomic Product
 Table 86. Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 87. Eurofins Scientific Recent Development
 Table 88. Sequentia Biotech SL Company Details
 Table 89. Sequentia Biotech SL Business Overview
 Table 90. Sequentia Biotech SL RNA Analysis & Transcriptomic Product
 Table 91. Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 92. Sequentia Biotech SL Recent Development
 Table 93. Acobiom Company Details
 Table 94. Acobiom Business Overview
 Table 95. Acobiom RNA Analysis & Transcriptomic Product
 Table 96. Acobiom Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 97. Acobiom Recent Development
 Table 98. GenXPro GmbH Company Details
 Table 99. GenXPro GmbH Business Overview
 Table 100. GenXPro GmbH RNA Analysis & Transcriptomic Product
 Table 101. GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 102. GenXPro GmbH Recent Development
 Table 103. CD Genomics Company Details
 Table 104. CD Genomics Business Overview
 Table 105. CD Genomics RNA Analysis & Transcriptomic Product
 Table 106. CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 107. CD Genomics Recent Development
 Table 108. Promega Corporation Company Details
 Table 109. Promega Corporation Business Overview
 Table 110. Promega Corporation RNA Analysis & Transcriptomic Product
 Table 111. Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 112. Promega Corporation Recent Development
 Table 113. Cenix BioScience GmbH Company Details
 Table 114. Cenix BioScience GmbH Business Overview
 Table 115. Cenix BioScience GmbH RNA Analysis & Transcriptomic Product
 Table 116. Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 117. Cenix BioScience GmbH Recent Development
 Table 118. Takara Holdings, Inc. Company Details
 Table 119. Takara Holdings, Inc. Business Overview
 Table 120. Takara Holdings, Inc. RNA Analysis & Transcriptomic Product
 Table 121. Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 122. Takara Holdings, Inc. Recent Development
 Table 123. bioMérieux SA Company Details
 Table 124. bioMérieux SA Business Overview
 Table 125. bioMérieux SA RNA Analysis & Transcriptomic Product
 Table 126. bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 127. bioMérieux SA Recent Development
 Table 128. LC Sciences LLC Company Details
 Table 129. LC Sciences LLC Business Overview
 Table 130. LC Sciences LLC RNA Analysis & Transcriptomic Product
 Table 131. LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2020-2025) & (US$ Million)
 Table 132. LC Sciences LLC Recent Development
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. RNA Analysis & Transcriptomic Picture
 Figure 2. Global RNA Analysis & Transcriptomic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global RNA Analysis & Transcriptomic Market Share by Type: 2024 VS 2031
 Figure 4. Microarrays Features
 Figure 5. Sequencing Features
 Figure 6. Polymerase Chain Reaction Features
 Figure 7. RNA Interference Features
 Figure 8. Global RNA Analysis & Transcriptomic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global RNA Analysis & Transcriptomic Market Share by Application: 2024 VS 2031
 Figure 10. Clinical Diagnostics Case Studies
 Figure 11. Drug Discovery Case Studies
 Figure 12. Toxicogenomics Case Studies
 Figure 13. Comparative Transcriptomics Case Studies
 Figure 14. RNA Analysis & Transcriptomic Report Years Considered
 Figure 15. Global RNA Analysis & Transcriptomic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global RNA Analysis & Transcriptomic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global RNA Analysis & Transcriptomic Market Share by Region: 2024 VS 2031
 Figure 18. Global RNA Analysis & Transcriptomic Market Share by Players in 2024
 Figure 19. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by RNA Analysis & Transcriptomic Revenue in 2024
 Figure 21. North America RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America RNA Analysis & Transcriptomic Market Share by Country (2020-2031)
 Figure 23. United States RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe RNA Analysis & Transcriptomic Market Share by Country (2020-2031)
 Figure 27. Germany RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific RNA Analysis & Transcriptomic Market Share by Region (2020-2031)
 Figure 35. China RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America RNA Analysis & Transcriptomic Market Share by Country (2020-2031)
 Figure 43. Mexico RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa RNA Analysis & Transcriptomic Market Share by Country (2020-2031)
 Figure 47. Turkey RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE RNA Analysis & Transcriptomic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Thermo Fisher Scientific, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 51. Bio-Rad Laboratories, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 52. Merck KGaA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 54. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 55. Danaher Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 56. Fluidigm Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 57. Eurofins Scientific Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 58. Sequentia Biotech SL Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 59. Acobiom Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 60. GenXPro GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 61. CD Genomics Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 62. Promega Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 63. Cenix BioScience GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 64. Takara Holdings, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 65. bioMérieux SA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 66. LC Sciences LLC Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String